The 3 T’s: Positioning Ireland for FDI
What makes Ireland attractive for FDI? As the former general manager of Genzyme’s Waterford site, Pat O’Sullivan explains that a longstanding 12.5% corporate tax rate (that isn’t going anywhere)…
Address: Kevin O’Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2,Ireland
Tel: 353-1-676 4971
Web: http://www.imb.ie/
The mission of the Irish Medicines Board (IMB) is
‘to protect and enhance public and animal health through the regulation of medicines, medical devices and healthcare products’
The objective of the IMB is to ensure in so far as possible, consistent with current medical and scientific knowledge, the quality, safety and efficacy of medicines available in Ireland and to participate in systems designed to do that throughout the European Union. Before a medicine can be authorised for use, an application must be made to the IMB and this must contain all of the necessary data supporting its quality, safety and efficacy.
The IMB is committed to the implementation and maintenance of a documented quality management system which is continually improved. The system is based on the requirements of the legislation, the regulatory system and ISO 9000:2000; it also takes into account guidelines, standards and best practices from Irish and international organisations.
What makes Ireland attractive for FDI? As the former general manager of Genzyme’s Waterford site, Pat O’Sullivan explains that a longstanding 12.5% corporate tax rate (that isn’t going anywhere)…
Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs. Nearby, Pfizer was manufacturing citric acid for…
“The elements that have made Ireland attractive for decades are still here. The big difference since 2007, however, is the cost base. If you are building a pharma plant…
Kells Stainless, founded in 1988, is celebrating 25 years this year. Looking back, what have been the company’s principal achievements over these decades? Originally, Kells Stainless was set up to…
Mr. Murphy, you first joined PM Group 24 years ago. How has the company, and the market, changed? My background, prior to joining PM Group, was in the pharmaceutical industry—I…
Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? Genzyme Waterford was set up in 2001, to support the manufacture of drug products for…
Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? Genzyme Waterford was set up in 2001, to support the manufacture of drug products for…
Fergal Murphy, Chairman of the Association of Pharmaceutical Manufacturers in Ireland, discusses with pharamaboardroom.com the difficulties in such a small market and how the industry is adapting to the needs…
Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some time as a post-doctoral researcher…
Can you please introduce yourself, and Ernst & Young’s life science practice in Ireland, to our readers? I am the managing partner of Ernst & Young (EY) in Ireland, responsible…
Can you please introduce our readers to ProTek Medical? ProTek Medical was founded in 1995 to serve a growing healthcare market by partnering closely with our customers in precision injection…
Mr. Callaghan, you have had quite a long and prestigious career in the pharmaceutical industry, with experience overseeing manufacturing programs for giants such as Amgen, BMS and Merck. Can you…
See our Cookie Privacy Policy Here
